Cost Utility Analysis of Screening for Diabetic Retinopathy by a Computerized Simulation Model

计算机模拟模型筛查糖尿病视网膜病变的成本效用分析

基本信息

  • 批准号:
    10672124
  • 负责人:
  • 金额:
    $ 1.02万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 1999
  • 项目状态:
    已结题

项目摘要

( 1 ) Cost utility analysisTo assess the efficiency of the periodic examinations of detecting diabetic retinopathy, a Markov decision analytic model was constructed to compare four detecting strategies : 6-, 12-, 24-, 36-month interval screenings. The clinical effect on quality of life was expressed as quality-adjusted life years (QALYs). The costs were estimated from medical charge lists of the health insurance system in Japan. Our model showed that screening strategies would reduce visual loss and improve quality of life in individuals and that the incremental cost-effectiveness ratio of 6-month interval strategy, 4,571,800 yen/QALYs, would be very high compared with 12-month interval strategy, 662,100 yen/QALYs. The estimation not only from insurer's viewpoint but also from societal viewpoint is necessary to the appropriate evaluation of the efficiency.( 2 ) Subjective health values of diabetic patientsWe examined preferences for current health states in hospitalized patients with d … More iabetes using the rating scale (RS) and the standard gamble (SG), and evaluated the relation between their utility values and the other characteristics. Age and diabetes duration were related to the RS scores. Diabetic states such as glycosylated hemoglobin levels, diabetic complications and daily insulin injections did not influence both the RS scores and the SG scores. The individuals who desired to extend their life rather than to relieve pain provided significant higher RS scores than those who did not desire. Of personality factors, extracted from personality questionnaires by factor analysis, the "steadiness" correlated modestly and "tendency to give up" correlated inversely with the SG scores. Current subjective health values among diabetic patients varied widely and did not relate well to their diabetic states. In clinical practice of diabetes, not only objective clinical indicators but also subjective health values for diabetic states should be fully incorporated into the process of clinical decision making. Less
(1)成本效用分析为评价糖尿病视网膜病变定期检查的效率,构建了马尔可夫决策分析模型,比较了4种检测策略:6个月、12个月、24个月、36个月的间隔筛查。临床对生活质量的影响以质量调整寿命年(QALYs)表示。费用是从日本医疗保险系统的医疗费用清单中估计出来的。我们的模型表明,筛查策略将减少视力损失并提高个体的生活质量,6个月间隔策略的增量成本-效果比为4,571,800日元/QALY,而12个月间隔策略的增量成本-效果比为662,100日元/QALY。不仅从保险公司的角度,而且从社会的角度进行评估,对于适当地评估效率是必要的。(2)糖尿病患者的主观健康价值我们调查了d-…住院患者对当前健康状态的偏好采用评定量表(RS)和标准赌博量表(SG)对糖尿病患者进行评分,并评价其实用价值与其他指标的关系。年龄、糖尿病病程与RS评分有关。糖化血红蛋白水平、糖尿病并发症和每日胰岛素注射等糖尿病状态对RS评分和SG评分均无影响。那些希望延长寿命而不是缓解疼痛的人比那些不想要的人提供了显著更高的RS分数。在人格因素中,通过因子分析从人格问卷中提取的“稳重”和“放弃倾向”与SG得分呈负相关。目前糖尿病患者的主观健康值差异很大,与他们的糖尿病状态没有很好的关系。在糖尿病的临床实践中,不仅要有客观的临床指标,还要有糖尿病状态的主观健康值,充分融入到临床决策过程中。较少

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
大澤 功: "決断分析による糖尿病網膜症スクリーニングの検討" 第18回医療情報学連合大会論文集. 174-175 (1998)
Isao Osawa:“使用决策分析进行糖尿病视网膜病变筛查”第 18 届医学信息学联盟会议记录 174-175 (1998)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
大澤 功: "決断分析による糖尿病網膜症スクリーニングの検討"第18回医療情報学連合大会論文集. 174-175 (1998)
Isao Osawa:“使用决策分析进行糖尿病视网膜病变筛查”第 18 届联合医学信息学会议论文集 174-175 (1998)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ohsawa, Isao: "Decision analysis of the screening for diabetic retinopathy"Proceedings of the 18 th Joint Conference on Medical Informatics. 174-175 (1998)
Ohsawa, Isao:“糖尿病视网膜病变筛查的决策分析”第 18 届医学信息学联席会议论文集。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OHSAWA Isao其他文献

OHSAWA Isao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OHSAWA Isao', 18)}}的其他基金

Pathogenesis of encapsulating peritoneal sclerosis in the role of complement regulatory proteins and glycation
补体调节蛋白和糖化作用中包裹性腹膜硬化的发病机制
  • 批准号:
    23591482
  • 财政年份:
    2011
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cost-effective evaluation of health education programs
健康教育计划的成本效益评估
  • 批准号:
    19500586
  • 财政年份:
    2007
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cost and benefit of the genetic diagnosis for diabetes mellitus as a screening test.
糖尿病基因诊断作为筛查测试的成本和效益。
  • 批准号:
    17590450
  • 财政年份:
    2005
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Evaluation and dissemination of evidence-based health information about the effectiveness of exercise and physical activity
评估和传播有关锻炼和体育活动有效性的循证健康信息
  • 批准号:
    15500476
  • 财政年份:
    2003
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Evaluating equitable access to diabetic retinopathy screening using social value judgement informed distributional cost-effectiveness analyses (Oppression framework informed equity cost-effectiveness analysis of diabetic retinopathy screening)
使用社会价值判断知情的分配成本效益分析评估糖尿病视网膜病变筛查的公平性(压迫框架知情的糖尿病视网膜病变筛查公平成本效益分析)
  • 批准号:
    495212
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
OCTA Precursors of Vision-Threatening Complications of Diabetic Retinopathy
OCTA 糖尿病视网膜病变视力威胁并发症的前兆
  • 批准号:
    10718643
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
The Genetic Architecture of Diabetic Retinopathy
糖尿病视网膜病变的遗传结构
  • 批准号:
    10605816
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
Automated system to improve compliance to diabetic retinopathy screening
自动化系统可提高糖尿病视网膜病变筛查的依从性
  • 批准号:
    10697609
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
Extracellular Vesicle Therapy for Diabetic Retinopathy
细胞外囊泡治疗糖尿病视网膜病变
  • 批准号:
    10723000
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
Automated Digital Diabetic Retinopathy Eye Screening System (ADDRESS)
自动数字糖尿病视网膜病变眼部筛查系统(ADDRESS)
  • 批准号:
    10034967
  • 财政年份:
    2022
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Collaborative R&D
Treating early stage diabetic retinopathy
治疗早期糖尿病视网膜病变
  • 批准号:
    10656335
  • 财政年份:
    2022
  • 资助金额:
    $ 1.02万
  • 项目类别:
Preventing Vision Loss from Diabetic Retinopathy: Guiding Primary Care Diabetic Retinopathy Screening in Canada Through the Use of Provincial Healthcare Administrative Data
预防糖尿病视网膜病变导致的视力丧失:通过使用省级医疗保健管理数据指导加拿大初级保健糖尿病视网膜病变筛查
  • 批准号:
    454377
  • 财政年份:
    2021
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Operating Grants
The role of IL-17A in the onset and progression of diabetic retinopathy in VA patients
IL-17A 在 VA 患者糖尿病视网膜病变发生和进展中的作用
  • 批准号:
    10426051
  • 财政年份:
    2021
  • 资助金额:
    $ 1.02万
  • 项目类别:
Microglia-Vascular Interaction in Alteration of Blood-Retinal Barrier in Diabetic Retinopathy
小胶质细胞-血管相互作用在糖尿病视网膜病变血-视网膜屏障改变中的作用
  • 批准号:
    10512065
  • 财政年份:
    2021
  • 资助金额:
    $ 1.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了